Abstract

Isoniazid Release from Suppositories Compounded with Selected Bases

Author(s): Hudson Kristofer C, Asbill C Scott, Webster Andrew A

Issue: Sep/Oct 2007 - Veterinary Compounding

Page(s): 433-437

Download in electronic PDF format for $75
  • Isoniazid Release from Suppositories Compounded with Selected Bases Page 1
  • Isoniazid Release from Suppositories Compounded with Selected Bases Page 2
  • Isoniazid Release from Suppositories Compounded with Selected Bases Page 3
  • Isoniazid Release from Suppositories Compounded with Selected Bases Page 4
  • Isoniazid Release from Suppositories Compounded with Selected Bases Page 5

Abstract

There is an increasing need for an alternative route of isoniazid administration for prophylaxis and treatment of tuberculosis in children. The purpose of this study is to evaluate the in vitro release of isoniazid from extemporaneously compounded isoniazid suppositories with a goal of optimizing the suppository dosage form for this indication. Suppositories were compounded using three different base formulations (cocoa butter, Witepsol H15 Base F, and a combination of polyethylene glycols 3350, 1000, and 400). The release profiles of six compounded suppositories with isoniazid (100 mg) were tested with a United States Pharmacopeial Convention–approved dissolution apparatus. Isoniazid concentrations at predetermined time points were determined using high-performance liquid chromatographic analysis. The results show that drug release from the water-soluble base (mixed polyethylene glycols) was significantly greater than that from the lipophilic bases (cocoa butter and Witepsol H15). The percentage of isoniazid release from the polyethylene glycol suppository formulation (70 ± 1.4 mg/mL) was greater than that from the cocoa butter (55 ± 1.1 mg/mL) and Witepsol H15 Base F (18 ± 0.36 mg/mL) suppository formulations.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2007
Pg. 433-437
Jul/Aug 2021
Pg. 304-309
Author(s): Allen Loyd V Jr
Mar/Apr 1997
Pg. 93-99
Sep/Oct 1998
Pg. 390-393
Mar/Apr 2020
Pg. 98-102
Author(s): Riepl Mike
Jan/Feb 1998
Pg. 66
Author(s): Allen Loyd V Jr
Jul/Aug 2022
Pg. 302-307
Author(s): Allen Loyd V Jr
Jan/Feb 2022
Pg. 34-38
Author(s): Allen Loyd V Jr
Jul/Aug 2004
Pg. 310-312
Nov/Dec 2011
Pg. 510-514
May/Jun 2013
Pg. 232
Author(s): Allen Loyd V Jr
Jul/Aug 2013
Pg. 334
Author(s): Allen Loyd V Jr
Jan/Feb 2020
Pg. 58
Author(s): Allen Loyd V Jr
Sep/Oct 2003
Pg. 376
Author(s): Allen Loyd V Jr
Nov/Dec 2020
Pg. 501-508
Jan/Feb 1998
Pg. 83-88
May/Jun 2001
Pg. 234-237
Sep/Oct 2021
Pg. 427-430
Jul/Aug 2002
Pg. 303-304
Author(s): Allen Loyd V Jr
Jul/Aug 2000
Pg. 289-293
Author(s): Allen Loyd V Jr